Table: RaQualia Pharma -Q1 group results

RaQualia Pharma

11/05/2018 07:15

May 11 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Mar 31, 2018        Mar 31, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            396 mln             417 mln            1.39      
                 (-5.1 pct)                            (-2.2 pct)   
  Operating     loss 240 mln         loss 59 mln      loss 698 mln  
  Recurring     loss 285 mln         loss 74 mln      loss 680 mln  
  Net           loss 311 mln         loss 65 mln      loss 686 mln  
  EPS          loss 15.33 yen       loss 3.44 yen    loss 33.84 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T